Clinical use of hematopoietic growth factors

Authors

  • José Domingo Torres Hernández Universidad de Antioquia

DOI:

https://doi.org/10.17533/udea.iatreia.3563

Keywords:

Neutropenia, Thrombocytopenia, Hematopoietic growth factors, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor

Abstract

Hematopoietic growth factors are one of the products of the exciting and promising molecular biology and genetic engineering industries. Two of these factors are the recombinant human - granulocyte colony-stimulating factor and the recombinant human-granulocyte-macrophage colony-stimulating factor; a review Is presented on their pharmacology and clinical uses in acute neutropenia after myelotoxic anticancer therapy, bone marrow transplantion, acute leukemia, myelodyplastic syndromes, aplastic anemia, AIDS and chronic neutropenia.

|Abstract
= 819 veces | PDF (ESPAÑOL (ESPAÑA))
= 299 veces|

Downloads

Download data is not yet available.

Author Biography

José Domingo Torres Hernández, Universidad de Antioquia

Profesor Asistente, Departamento de Medicina Interna, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Downloads

Published

1994-04-15

How to Cite

1.
Torres Hernández JD. Clinical use of hematopoietic growth factors. Iatreia [Internet]. 1994 Apr. 15 [cited 2025 Feb. 2];7(4):pág. 173-180. Available from: https://revistas.udea.edu.co/index.php/iatreia/article/view/3563

Issue

Vol 7, No 4

Section

Review articles

License

Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.

The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.

Crossref
Scopus
Google Scholar
Europe PMC